Dual-view jointly learning improves personalized drug synergy prediction
Bioinformatics · 2024
DOI: 10.1093/bioinformatics/btae604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2024. Verfasst von Xueliang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy o…. Hauptthemen laut MEDLINE: Precision Medicine, Drug Synergism, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, CAS Youth Innovation Promotion Association.
Abstract (Originalsprache)
Motivation Accurate and robust estimation of the synergistic drug combination is important for medicine precision. Although some computational methods have been developed, some predictions are still unreliable especially for the cross-dataset predictions, due to the complex mechanism of drug combinations and heterogeneity of cancer samples. Results We have proposed JointSyn that utilizes dual-view jointly learning to predict sample-specific effects of drug combination from drug and cell features. JointSyn outperforms existing state-of-the-art methods in predictive accuracy and robustness across various benchmarks. Each view of JointSyn captures drug synergy-related characteristics and makes complementary contributes to the final prediction of the drug combination. Moreover, JointSyn with fine-tuning improves its generalization ability to predict a novel drug combination or cancer sample using a small number of experimental measurements. We also used JointSyn to generate an estimated atlas of drug synergy for pan-cancer and explored the differential pattern among cancers. These results demonstrate the potential of JointSyn to predict drug synergy, supporting the development of personalized combinatorial therapies. Availability and implementation Source code and data are available at https://github.com/LiHongCSBLab/JointSyn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
- Bio-Med Big Data Center, CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Science, Shanghai 200031, China.
ORCID-Profile: Xueliang Li, Bihan Shen, Fangyoumin Feng, Liangxiao Ma, Hong Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- CAS Youth Innovation Promotion Association
Zitieren
APA
Li, X., Shen, B., Feng, F., Li, K., Tang, Z., Ma, L., & Li, H. (2024). Dual-view jointly learning improves personalized drug synergy prediction. Bioinformatics. https://doi.org/10.1093/bioinformatics/btae604
Vancouver
Li X, Shen B, Feng F, Li K, Tang Z, Ma L, et al. Dual-view jointly learning improves personalized drug synergy prediction. Bioinformatics. 2024. doi:10.1093/bioinformatics/btae604
BibTeX
@article{Li2024,
author = {Li, Xueliang and Shen, Bihan and Feng, Fangyoumin and Li, Kunshi and Tang, Zhixuan and Ma, Liangxiao and Li, Hong},
title = {Dual-view jointly learning improves personalized drug synergy prediction},
journal = {Bioinformatics},
year = {2024},
doi = {10.1093/bioinformatics/btae604}
}
EUVIMED